金新農(002548.SZ):在廣東省內的養殖場的生豬銷售面向大灣區
格隆匯5月18日丨有投資者在投資者互動平台向金新農(002548.SZ)提問,“2022年7月份,有新聞表示深圳市市場監管局與貴公司有簽訂生豬產銷戰略合作框架協議,根據協議將以深圳為中心,向大灣區每年提供超過400萬頭的生豬及各類肉製品,為深圳生豬供應奠定更堅實的基礎,作為深圳市本土企業,請問截止目前,貴公司有無實際合作項目落地,未來有無推進實際合作的決策,目前公司對深圳和大灣區每年大概提供生豬多少萬頭?”
金新農回覆稱,公司在廣東省內的養殖場的生豬銷售面向大灣區,公司旗下韶關市武江區優百特養殖有限公司生豬養殖基地入選2022年深圳市菜籃子基地認定名單。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.